The global microbial cellulose market revenue was around US$ 20.7 million in 2022 and is estimated to reach US$ 58.3 million by 2031, growing at a compound annual growth rate (CAGR) of 12.2% during the forecast period from 2023 to 2031.
Microbial cellulose, also known as biocellulose or bacterial cellulose, is produced by aerobic bacteria, like acetic acid bacteria of the genus Gluconacetobacter xylinum. It is produced as a polymer and nanomaterial by biotechnologically assembled methods from low-molecular-weight carbon sources. Microbial cellulose is produced by a variety of microorganisms when they ferment substances in an agitated or static manner with the help of suitable conditions. The highest yield of microbial cellulose is provided by agitated cultivation when compared to static cultivation.
Market Driving Factors
Increasing demand for microbial cellulose from healthcare is expected to drive the market. Microbial cellulose is used in the creation of materials or devices for wound healing. Additionally, Microbial cellulose is employed as a scaffold for skin engineering after being seeded with epithelial cells. Furthermore, microbial cellulose is usually low cytotoxicity, and nontoxic is observed. Microbial cellulose possesses physical and chemical characteristics that make it a good material for reconstructive surgery when modified. Microbial cellulose is a great material for surgical implants because of its mechanical qualities, which include high tensile strength, flexibility, and water retention rate, low inflammation induction, and low levels of cytotoxic effects.
Growing uses in the cosmetics sector will drive market growth. Cosmetics producers are investigating cutting-edge methods and materials to lessen their influence on the environment. Microbial cellulose is a sustainable and natural substance praised by cosmetic producers due to its skin adherence, biocompatibility, and water retention qualities. The majority of microbial cellulose is used to create sheet masks for cosmetics. These masks have outstanding moisture retention qualities due to their three-dimensional nanostructure, which absorbs active hydrophilic substances including moisturizers and anti-aging agents.
The rising cost associated with microbial cellulose production is expected to hamper the market growth.
Regional Analysis
Asia-Pacific dominates the market in terms of revenue during the forecast period. Environmental pollution has increased recently as a result of the increased usage of cosmetics and personal care items derived from harmful raw ingredients. According to Frontiers Media S.A. microbead-containing personal care and cosmetic products are widely accessible for purchase in the region, with over 70% of these items containing at least one type of microbead, with polyethylene being the most popular. Therefore, microbial cellulose is biodegradable and does not harm the environment making it a suitable biomaterial for use in cosmetics and personal care products.
Segmentation Analysis
Growth Medium Insight
The synthetic segment dominated the market in terms of revenue. Acetobacter xylinum subsp. Sucrofermentans discovered corn steep liquor (CSL) is the most effective medium for the synthesis of microbial cellulose. The lactate found in CSL works by joining with the respiratory chain to produce energy for development and encourages cell proliferation in the early stages of culture. A xylinum is the source of bacterial cellulose that is most frequently researched since it can produce high levels of polymer from a wide variety of nitrogen and carbon sources. The Hestrin-Schramm medium (HS), which contains 2% glucose, 0.5% peptone, 0.5% yeast extract, 0.27% Na2HPO4, and 1.15 g/L citric acid, is the most widely used synthetic medium for the production of microbial cellulose.
Application Insight
The medical segment dominated the market in terms of revenue. Microbial cellulose is used as a biomaterial and utilized in several applied scientific areas, like biomedical devices. Biomedical materials have become more and more common in recent years due to a rise in interest in tissue engineering materials for wound care and regenerative medicine.
Prominent Companies
Segmentation Outline
The global microbial cellulose market segmentation focuses on Growth Medium, Application, and Region.
By Growth Medium
By Application
By Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL MICROBIAL CELLULOSE MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY: MICROBIAL CELLULOSE MARKET
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
3.5 ANALYST TOOLS AND MODELS
4 GLOBAL MICROBIAL CELLULOSE MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS AND TRENDS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 MARKET GROWTH AND OUTLOOK
4.5.1 PRICE TREND ANALYSIS
4.5.2 OPPORTUNITY SHARE
5 GLOBAL MICROBIAL CELLULOSE MARKET, BY GROWTH MEDIUM
5.1 OVERVIEW
5.2 SYNTHETIC
5.3 NATURAL
6 GLOBAL MICROBIAL CELLULOSE MARKET, BY APPLICATION
6.1 OVERVIEW
6.2 MEDICAL
6.3 COSMETICS AND PERSONAL CARE
6.4 PAPER
6.5 TEXTILE
6.6 FOOD AND BEVERAGE
6.7 OTHERS
7 GLOBAL MICROBIAL CELLULOSE MARKET, BY GEOGRAPHY
7.1 OVERVIEW
7.2 NORTH AMERICA
7.2.1 NORTH AMERICA MARKET SNAPSHOT
7.2.2 U.S.
7.2.3 CANADA
7.2.4 MEXICO
7.3 EUROPE
7.3.1 EUROPE MARKET SNAPSHOT
7.3.2 WESTERN EUROPE
7.3.2.1 THE UK
7.3.2.2 GERMANY
7.3.2.3 FRANCE
7.3.2.4 ITALY
7.3.2.5 SPAIN
7.3.2.6 REST OF WESTERN EUROPE
7.3.3 EASTERN EUROPE
7.3.3.1 POLAND
7.3.3.2 RUSSIA
7.3.3.3 REST OF EASTERN EUROPE
7.4 ASIA PACIFIC
7.4.1 ASIA PACIFIC MARKET SNAPSHOT
7.4.2 CHINA
7.4.3 JAPAN
7.4.4 INDIA
7.4.5 AUSTRALIA & NEW ZEALAND
7.4.6 ASEAN
7.4.7 REST OF ASIA PACIFIC
7.5 MIDDLE EAST & AFRICA
7.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
7.5.2 UAE
7.5.3 SAUDI ARABIA
7.5.4 SOUTH AFRICA
7.5.5 REST OF MEA
7.6 SOUTH AMERICA
7.6.1 SOUTH AMERICA MARKET SNAPSHOT
7.6.2 BRAZIL
7.6.3 ARGENTINA
7.6.4 REST OF SOUTH AMERICA
8 GLOBAL MICROBIAL CELLULOSE MARKET COMPETITIVE LANDSCAPE
8.1 OVERVIEW
8.2 COMPANY MARKET RANKING
8.3 KEY DEVELOPMENT STRATEGIES
8.4 COMPETITIVE DASHBOARD
8.5 PRODUCT MAPPING
8.6 TOP PLAYER POSITIONING, 2022
8.7 COMPETITIVE HEATMAP
8.8 TOP WINNING STRATEGIES
9 COMPANY PROFILES
9.1 BORREGAARD AS
9.1.1 OVERVIEW
9.1.2 FINANCIAL PERFORMANCE
9.1.3 PRODUCT OUTLOOK
9.1.4 KEY DEVELOPMENTS
9.1.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.2 AXCELON BIOPOLYMERS CORPORATION MERCK KGAA
9.2.1 OVERVIEW
9.2.2 FINANCIAL PERFORMANCE
9.2.3 PRODUCT OUTLOOK
9.2.4 KEY DEVELOPMENTS
9.2.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.3 ASHLAND
9.3.1 OVERVIEW
9.3.2 FINANCIAL PERFORMANCE
9.3.3 PRODUCT OUTLOOK
9.3.4 KEY DEVELOPMENTS
9.3.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.4 HBBE
9.4.1 OVERVIEW
9.4.2 FINANCIAL PERFORMANCE
9.4.3 PRODUCT OUTLOOK
9.4.4 KEY DEVELOPMENTS
9.4.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.5 BACPOLYZYME
9.5.1 OVERVIEW
9.5.2 FINANCIAL PERFORMANCE
9.5.3 PRODUCT OUTLOOK
9.5.4 KEY DEVELOPMENTS
9.5.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.6 BIOESQUE
9.6.1 OVERVIEW
9.6.2 FINANCIAL PERFORMANCE
9.6.3 PRODUCT OUTLOOK
9.6.4 KEY DEVELOPMENTS
9.6.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.7 HYSSES
9.7.1 OVERVIEW
9.7.2 FINANCIAL PERFORMANCE
9.7.3 PRODUCT OUTLOOK
9.7.4 KEY DEVELOPMENTS
9.7.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.8 HNB BIO CO LTD
9.8.1 OVERVIEW
9.8.2 FINANCIAL PERFORMANCE
9.8.3 PRODUCT OUTLOOK
9.8.4 KEY DEVELOPMENTS
9.8.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.9 BOWIL BIOTECH SP. Z. O.O.
9.9.1 OVERVIEW
9.9.2 FINANCIAL PERFORMANCE
9.9.3 PRODUCT OUTLOOK
9.9.4 KEY DEVELOPMENTS
9.9.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved